Article
NQO1, MPO, and the risk of lung cancer: a HuGE review.
Genetics in medicine : official journal of the American College of Medical Genetics - 1 Sept 2005
Kiyohara Chikako, Yoshimasu Kouichi, Takayama Koichi, Nakanishi Yoichi
Abstract excerpt
The aim of this study is to summarize the available molecular epidemiologic studies of lung cancer and metabolic genes, such as NAD(P)H quinone reductase 1 (NQO1) and myeloperoxidase (MPO). NQO1 plays a dual role in the detoxification and activation of procarcinogens whereas MPO has Phase I activity by converting lipophilic carcinogens into hydrophilic forms. Variant genotypes of both NQO1 Pro187 Ser and MPO...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
